C
GMAB icon

Covestor’s Genmab GMAB Stock Holding History

Covestor’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-853
Closed -$30K – 2335
2023
Q3 		$30K Sell
853
-54
-6% -$2.06K 0.02% 979
2023
Q2 		$34K Sell
907
-24
-3% -$957 0.03% 934
2023
Q1 		$35K Buy
931
+43
+5% +$1.65K 0.03% 845
2022
Q4 		$38K Sell
888
-26
-3% -$1.07K 0.03% 833
2022
Q3 		$29K Buy
914
+16
+2% +$562 0.03% 900
2022
Q2 		$29K Sell
898
-39
-4% -$1.26K 0.02% 895
2022
Q1 		$34K Sell
937
-8
-0.8% -$275 0.02% 921
2021
Q4 		$37K Buy
+945
New +$39.4K 0.05% 689

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Covestor's GMAB Position: Q4 2023 in Review

Covestor sold out of Genmab (GMAB) in Q4 2023, closing a stake of 853 shares — an estimated $30K sold.

Covestor first reported a position in GMAB in Q4 2021 and held it in 8 quarters. The position peaked at $38K in Q4 2022. 225 funds tracked by Wall St. Rank hold GMAB as of Q4 2023.

  • Covestor reported no remaining Genmab position as of Q4 2023 after selling out during the quarter.
  • Covestor sold 853 Genmab shares in Q4 2023, an estimated $30K.
  • Covestor first reported a position in Genmab in Q4 2021 and held it in 8 quarters.
  • Covestor's Genmab position peaked at $38K in Q4 2022.
  • 225 funds tracked by Wall St. Rank held Genmab as of Q4 2023.

Based on Covestor's 13F filing for Q4 2023, filed 9 Feb 2024.